Background
Cognitive deficits are common in patients with substance use disorder (SUD) and can impact treatment outcomes. The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) is a widely used tool that could help...
Background
A non-medicalized safer supply model called a “Compassion Club” has recently been evaluated. The model involved providing rigorously tested and accurately labeled illicit substances to members at cost. Operating for 14 months in...
Addiction and obesity share similar neurological pathways, both linked to compulsive behaviors and the brain's reward system. Research has highlighted the potential of GLP-1 receptor agonists, originally developed for diabetes, to help...
Background
The opioid epidemic in the U.S. contributes to increased morbidity and mortality from drug overdoses, but barriers to traditional opioid use disorder (OUD) treatment limit access to care. During the COVID-19 pandemic, Public...
Background
Heavy alcohol consumption increases the risk of developing tuberculosis (TB), delays diagnosis, and affects treatment adherence. This study aimed to examine the prevalence of alcohol use disorder (AUD) among individuals with TB...
Substance use surveillance has emerged as a crucial public health strategy across Africa, particularly in light of the alarming rise in substance use among adolescents (1). This trend poses significant health risks that require a...
Abstract
Objective: This study explores trends in the disposable e-cigarette market in the USA, specifically focusing on changes in e-cigarette size, nicotine strength, and real sales-weighted average prices, both per e-cigarette unit and...
Join the National Institute on Drug Abuse (NIDA) International Program for the 2025 NIDA International Forum, which will be held June 13–14, 2025, at the Sheraton New Orleans Hotel in New Orleans, Louisiana, USA.
The Forum research...
Evidence-based practice (EBP) serves as the foundation for effective prevention strategies, ensuring interventions, programmes, and policies are grounded in the best available scientific knowledge.
This guide presents a curated collection...
The UNODC #ScaleUp Initiative is a vital response to the growing global challenge of stimulant use disorders, which affect millions of individuals worldwide. In 2021, approximately 78 million people used substances like amphetamines...
The National Survey of Substance Use and Mental Health Services (N-SUMHSS) is a voluntary, annual survey that collects data from all active substance use and mental health treatment facilities across the United States, its territories, and...
INTRODUCTION: According to Brichcín (1999), a self-regulating person is someone who can resist the temptation of immediate gratification of their needs and is capable of achieving challenging goals. Self-regulation represents the ability to...
Prevention aligned with science and standards advocates for a person-focused rather than a drug-focused perspective when articulating responses and services. Such a perspective follows a narrative that early initiation to substance use is...
The Power of Collaboration is a joint project between ISSUP and the GWN. This initiative delves into three critical areas in substance use disorder (SUD) treatment for women:
MIND THE GAP: GLOBAL SURVEY EXAMINING ACCESS FOR SUBSTANCE...
English:
The comorbidity between depression and alcohol consumption is a public health concern, affecting progression, treatment adherence, and outcomes. Alcohol use in Latin America exceeds the global average. This study examined the...
10 щорічна конференція Асоціації психіатрів України з міжнародною участю «Можливості у сфері психічного здоров’я в країні, що перебуває у стані війни» відбулася у Києві 10-11 жовтня 2024 р. у гібридному форматі (офлайн і онлайн).
В...
A study was conducted to examine how patterns of alcohol and cannabis use are associated with bystander intervention in situations involving the risk of sexual and relationship violence among college students. Researchers aimed to explore...
Psychedelics have been used across different cultures for thousands of years, with historical evidence of substances like ayahuasca in South America, mescaline from cacti in North and South America, and ibogaine in West Africa. Despite this...
